Filing Details
- Accession Number:
- 0001487371-17-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-20 18:48:03
- Reporting Period:
- 2017-01-19
- Filing Date:
- 2017-01-20
- Accepted Time:
- 2017-01-20 18:48:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1487371 | Genmark Diagnostics Inc. | GNMK | Surgical & Medical Instruments & Apparatus (3841) | 272053069 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1505035 | Anne Jennifer Williams | 5964 La Place Court Carlsbad CA 92008 | Svp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-19 | 5,240 | $0.00 | 153,737 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-01-19 | 17,826 | $0.00 | 171,563 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-19 | 9,301 | $12.47 | 162,262 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Market Stock Units | Disposition | 2017-01-19 | 5,240 | $0.00 | 5,240 | $0.00 |
| Common Stock | Market Stock Units | Disposition | 2017-01-19 | 9,159 | $0.00 | 9,159 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,236 | No | 4 | M | Direct | ||
| 18,319 | No | 4 | M | Direct |
Footnotes
- Based on actual achievement for the one-year performance period, the recipient was issued 194.6% of the market stock units ("MSUs") which vested as of December 31, 2016.
- The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted MSUs.
- Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index.
- The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.
- The MSUs vest in three equal installments, on each of December 31, 2016, December 31, 2017, and December 31, 2018; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index
Billionaire Hedge Funds
